|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||3.2800 - 3.2800|
|52 Week Range||2.6000 - 14.0000|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
JACKSONVILLE, FL, May 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --mCig, Inc. (MCIG) CEO Paul Rosenberg publishes an open status letter to Shareholders. The cannabis industry received a surprise classification during the Covid-19 pandemic, - “essential business.” It’s not just the US — cannabis legalization and consumption is taking the whole world by storm.
JACKSONVILLE, FL, March 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced that the Financial Industry Regulatory Authority (FINRA) approved electronic quotation on the OTC Bulletin Board of common shares of OBITX Inc, under the symbol OBTX. MCIG Inc, owns 49% of Obitx Inc. Recently satisfying all requirements of rule 15c2-11, OBTX has been granted a symbol to be listed on the OTC Markets making the company stock more attractive to potential investors and increasing visibility within U.S. equity markets.